Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
Advanced hepatic fibrosis therapy using drug-delivering nanoparticles is a relatively unexplored area. Angiotensin type 1 (AT1) receptor blockers such as losartan can be delivered to hepatic stellate cells (HSC), blocking their activation and thereby reducing fibrosis progression in the liver. In ou...
Main Authors: | Reju George Thomas, Myeong Ju Moon, Jo Heon Kim, Jae Hyuk Lee, Yong Yeon Jeong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4699854?pdf=render |
Similar Items
-
Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice.
by: Suchithra Poilil Surendran, et al.
Published: (2020-01-01) -
Biomedical Applications of Hyaluronic Acid-Based Nanomaterials in Hyperthermic Cancer Therapy
by: Subin Kim, et al.
Published: (2019-07-01) -
Hyaluronic Acid Micelles for Promoting the Skin Permeation and Deposition of Curcumin
by: Niu J, et al.
Published: (2022-09-01) -
Computational approach to the design of hyaluronic acid copolymer based doxorubicin micelles
by: Yujiao Sun, et al.
Published: (2016-02-01) -
Use of Hyaluronic Acid (HA) in Chronic Airway Diseases
by: Luis Máiz Carro, et al.
Published: (2020-09-01)